HPVC2019-159 Biopharmaceuticals Long-Acting Granulocyte-Colony Stimulating Factor
Current Contract
Description
Contract for the provision of long acting granulocyte colony-stimulating factor (G-CSF) to Victorian public hospitals and health services.Additional Information
Contract Details
The Principal Period (2 years) commenced on 28 June 2019 until 27 June 2021.
The first Contract Option period of two years has been executed - effective from 28 June 2021 until 27 June 2023.
The second Contract Option period of two years has been executed – effective from 28 June 2023 until 27 June 2025.
Option Periods Remaining
Nil.
Categories
Category 1: Biopharmaceuticals Long-Acting Granulocyte Colony-Stimulating Factor
Notes:
Please favourite this contract to receive updates
Please review your account settings to ensure the notification frequency selected is adequate